LifePoint Health Inc (NASDAQ:LPNT) – Equities researchers at Leerink Swann upped their FY2018 earnings estimates for LifePoint Health in a note issued to investors on Monday, Zacks Investment Research reports. Leerink Swann analyst A. Gupte now anticipates that the company will post earnings of $4.36 per share for the year, up from their previous forecast of $3.85. Leerink Swann currently has a “Market Perform” rating and a $58.00 target price on the stock. Leerink Swann also issued estimates for LifePoint Health’s FY2019 earnings at $5.00 EPS.
Other equities analysts also recently issued research reports about the stock. BidaskClub raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Thursday, January 11th. Morgan Stanley reaffirmed an “equal weight” rating and set a $46.00 price target (down previously from $50.00) on shares of LifePoint Health in a report on Monday, February 26th. ValuEngine downgraded shares of LifePoint Health from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. William Blair reaffirmed an “outperform” rating on shares of LifePoint Health in a report on Tuesday, November 21st. Finally, Royal Bank of Canada lowered their price target on shares of LifePoint Health to $58.00 and set an “outperform” rating on the stock in a report on Monday, February 26th. One analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $55.00.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.04). The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.58 billion. LifePoint Health had a return on equity of 6.34% and a net margin of 1.46%. The business’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.07 EPS.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Cerebellum GP LLC bought a new stake in LifePoint Health in the fourth quarter worth $126,000. State of Alaska Department of Revenue bought a new stake in LifePoint Health in the fourth quarter worth $134,000. US Bancorp DE increased its position in LifePoint Health by 62.4% in the fourth quarter. US Bancorp DE now owns 3,095 shares of the company’s stock worth $155,000 after purchasing an additional 1,189 shares during the last quarter. Xact Kapitalforvaltning AB bought a new stake in LifePoint Health in the fourth quarter worth $230,000. Finally, OxFORD Asset Management LLP bought a new stake in LifePoint Health in the third quarter worth $303,000.
In related news, insider David M. Dill sold 45,000 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total value of $2,183,400.00. Following the sale, the insider now owns 252,673 shares in the company, valued at $12,259,693.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman William F. Carpenter III purchased 21,368 shares of LifePoint Health stock in a transaction that occurred on Wednesday, February 28th. The stock was acquired at an average price of $46.80 per share, for a total transaction of $1,000,022.40. Following the transaction, the chairman now directly owns 482,668 shares of the company’s stock, valued at approximately $22,588,862.40. The disclosure for this purchase can be found here. Company insiders own 8.76% of the company’s stock.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.